Symbols / ISRG Stock $478.82 -0.99% Intuitive Surgical, Inc.
ISRG (Stock) Chart
About
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 170.06B | Enterprise Value | 163.66B | Income | 2.98B | Sales | 10.58B | Book/sh | 50.19 | Cash/sh | 22.48 |
| Dividend Yield | — | Payout | 0.00% | Employees | 17021 | IPO | — | P/E | 58.25 | Forward P/E | 40.79 |
| PEG | 2.49 | P/S | 16.07 | P/B | 9.54 | P/C | — | EV/EBITDA | 42.47 | EV/Sales | 15.47 |
| Quick Ratio | 5.17 | Current Ratio | 6.23 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | 8.22 | EPS next Y | 11.74 |
| EPS Growth | 18.80% | Revenue Growth | 23.00% | Earnings | 2026-07-21 | ROA | 10.26% | ROE | 17.23% | ROIC | — |
| Gross Margin | 66.35% | Oper. Margin | 31.08% | Profit Margin | 28.15% | Shs Outstand | 355.17M | Shs Float | 352.71M | Short Float | 1.91% |
| Short Ratio | 4.19 | Short Interest | — | 52W High | 603.88 | 52W Low | 427.84 | Beta | 1.68 | Avg Volume | 1.95M |
| Volume | 2.89M | Target Price | $577.68 | Recom | Buy | Prev Close | $483.62 | Price | $478.82 | Change | -0.99% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-23 | main | Barclays | Overweight → Overweight | $651 |
| 2026-04-22 | main | Leerink Partners | Outperform → Outperform | $573 |
| 2026-04-22 | main | Baird | Outperform → Outperform | $610 |
| 2026-04-22 | main | Piper Sandler | Overweight → Overweight | $580 |
| 2026-04-22 | reit | BTIG | Buy → Buy | $574 |
| 2026-04-15 | main | Truist Securities | Buy → Buy | $580 |
| 2026-04-13 | main | Mizuho | Neutral → Neutral | $525 |
| 2026-04-10 | reit | BTIG | Buy → Buy | $616 |
| 2026-04-09 | main | Goldman Sachs | Buy → Buy | $609 |
| 2026-04-06 | main | Evercore ISI Group | In-Line → In-Line | $480 |
| 2026-03-17 | main | UBS | Neutral → Neutral | $550 |
| 2026-03-11 | up | Citigroup | Neutral → Buy | $590 |
| 2026-02-24 | main | UBS | Neutral → Neutral | $570 |
| 2026-01-27 | up | Freedom Capital Markets | Hold → Buy | $610 |
| 2026-01-27 | init | TD Cowen | — → Buy | $660 |
| 2026-01-26 | main | Barclays | Overweight → Overweight | $712 |
| 2026-01-26 | up | Freedom Broker | Hold → Buy | $610 |
| 2026-01-23 | main | Citigroup | Neutral → Neutral | $590 |
| 2026-01-23 | main | Evercore ISI Group | In-Line → In-Line | $550 |
| 2026-01-23 | main | Piper Sandler | Overweight → Overweight | $620 |
- Why Robotic Surgery's Titan, Intuitive Surgical, Just Made A Bullish Move - Investor's Business Daily Wed, 22 Apr 2026 20
- Mizuho, BTIG, and Evercore Cut Intuitive Surgical (ISRG) Price Targets - Yahoo Finance ue, 21 Apr 2026 10
- ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth - Zacks Investment Research Wed, 22 Apr 2026 14
- Could Buying This Healthcare Stock Today Set You Up for Life? (Spoiler: It Certainly Could, As It Has Averaged Annual Gains of 21% Over the Past Decade.) - The Motley Fool Mon, 20 Apr 2026 12
- Intuitive Surgical Stock: Why an Earnings Beat Wasn’t Enough to Spark a Rally - Barron's Wed, 22 Apr 2026 11
- Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity - MarketBeat hu, 23 Apr 2026 14
- Why Intuitive Surgical (ISRG) Stock Is Up Today - Yahoo Finance UK hu, 23 Apr 2026 02
- ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill Mon, 20 Apr 2026 07
- Intuitive Surgical: Forget The 40x P/E. Focus On The 10-Year Potential (Upgrade) - Seeking Alpha hu, 23 Apr 2026 04
- Intuitive Surgical Inc Stock (ISRG) Closed Down by 3.00% on Apr 21: A Full Analysis - TradingKey ue, 21 Apr 2026 20
- QQQ is up 1.3% today, on ISRG stock price movement - Quiver Quantitative Wed, 22 Apr 2026 16
- Quick Pick: Intuitive Surgical, Inc (ISRG), Stock Pick From Jim Jubak, Jubak Picks Similar Website (iIYPgkj6ls) - Fathom Journal hu, 23 Apr 2026 05
- ISRG Maintains Overweight Rating by Barclays -- Price Target Low - GuruFocus hu, 23 Apr 2026 16
- [8-K] INTUITIVE SURGICAL INC Reports Material Event - Stock Titan ue, 21 Apr 2026 20
- ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth - Yahoo Finance Wed, 22 Apr 2026 15
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
10,064.70
+20.51%
|
8,352.10
+17.24%
|
7,124.10
+14.49%
|
6,222.20
|
| Operating Revenue |
|
10,064.70
+20.51%
|
8,352.10
+17.24%
|
7,124.10
+14.49%
|
6,222.20
|
| Cost Of Revenue |
|
3,422.40
+25.92%
|
2,717.90
+13.50%
|
2,394.60
+18.18%
|
2,026.20
|
| Reconciled Cost Of Revenue |
|
3,422.40
+25.92%
|
2,717.90
+13.50%
|
2,394.60
+18.18%
|
2,026.20
|
| Gross Profit |
|
6,642.30
+17.89%
|
5,634.20
+19.13%
|
4,729.50
+12.71%
|
4,196.00
|
| Operating Expense |
|
3,696.80
+12.53%
|
3,285.30
+10.89%
|
2,962.70
+13.13%
|
2,618.90
|
| Research And Development |
|
1,311.80
+14.54%
|
1,145.30
+14.67%
|
998.80
+13.63%
|
879.00
|
| Selling General And Administration |
|
2,385.00
+11.45%
|
2,140.00
+8.97%
|
1,963.90
+12.87%
|
1,739.90
|
| Total Expenses |
|
7,119.20
+18.59%
|
6,003.20
+12.06%
|
5,357.30
+15.33%
|
4,645.10
|
| Operating Income |
|
2,945.50
+25.40%
|
2,348.90
+32.95%
|
1,766.80
+12.03%
|
1,577.10
|
| Total Operating Income As Reported |
|
2,945.50
+25.40%
|
2,348.90
+32.95%
|
1,766.80
+12.03%
|
1,577.10
|
| EBITDA |
|
3,622.60
+27.17%
|
2,848.60
+28.22%
|
2,221.60
+14.34%
|
1,942.90
|
| Normalized EBITDA |
|
3,622.60
+27.17%
|
2,848.60
+28.22%
|
2,221.60
+14.34%
|
1,942.90
|
| Reconciled Depreciation |
|
677.10
+35.50%
|
499.70
+9.87%
|
454.80
+24.33%
|
365.80
|
| EBIT |
|
2,945.50
+25.40%
|
2,348.90
+32.95%
|
1,766.80
+12.03%
|
1,577.10
|
| Pretax Income |
|
3,311.40
+23.85%
|
2,673.80
+36.49%
|
1,958.90
+21.91%
|
1,606.80
|
| Net Non Operating Interest Income Expense |
|
365.90
+12.62%
|
324.90
+69.13%
|
192.10
+546.80%
|
29.70
|
| Net Interest Income |
|
365.90
+12.62%
|
324.90
+69.13%
|
192.10
+546.80%
|
29.70
|
| Interest Income Non Operating |
|
365.90
+12.62%
|
324.90
+69.13%
|
192.10
+546.80%
|
29.70
|
| Interest Income |
|
365.90
+12.62%
|
324.90
+69.13%
|
192.10
+546.80%
|
29.70
|
| Tax Provision |
|
434.80
+29.29%
|
336.30
+137.50%
|
141.60
-46.04%
|
262.40
|
| Tax Rate For Calcs |
|
0.00
+3.97%
|
0.00
+75.00%
|
0.00
-55.83%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
2,876.60
+23.06%
|
2,337.50
+28.62%
|
1,817.30
+35.18%
|
1,344.40
|
| Net Income From Continuing Operation Net Minority Interest |
|
2,856.00
+22.97%
|
2,322.60
+29.18%
|
1,798.00
+35.98%
|
1,322.30
|
| Net Income From Continuing And Discontinued Operation |
|
2,856.00
+22.97%
|
2,322.60
+29.18%
|
1,798.00
+35.98%
|
1,322.30
|
| Net Income Continuous Operations |
|
2,876.60
+23.06%
|
2,337.50
+28.62%
|
1,817.30
+35.18%
|
1,344.40
|
| Minority Interests |
|
-20.60
-38.26%
|
-14.90
+22.80%
|
-19.30
+12.67%
|
-22.10
|
| Normalized Income |
|
2,856.00
+22.97%
|
2,322.60
+29.18%
|
1,798.00
+35.98%
|
1,322.30
|
| Net Income Common Stockholders |
|
2,856.00
+22.97%
|
2,322.60
+29.18%
|
1,798.00
+35.98%
|
1,322.30
|
| Diluted EPS |
|
—
|
6.42
+27.63%
|
5.03
+37.81%
|
3.65
|
| Basic EPS |
|
—
|
6.54
+27.73%
|
5.12
+37.63%
|
3.72
|
| Basic Average Shares |
|
—
|
355.20
+1.14%
|
351.20
-1.27%
|
355.70
|
| Diluted Average Shares |
|
—
|
362.00
+1.29%
|
357.40
-1.27%
|
362.00
|
| Diluted NI Availto Com Stockholders |
|
2,856.00
+22.97%
|
2,322.60
+29.18%
|
1,798.00
+35.98%
|
1,322.30
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
20,458.70
+9.15%
|
18,743.20
+21.38%
|
15,441.50
+19.02%
|
12,974.00
|
| Current Assets |
|
9,779.50
+37.53%
|
7,111.00
-9.85%
|
7,888.00
+26.15%
|
6,253.00
|
| Cash Cash Equivalents And Short Term Investments |
|
5,934.90
+47.88%
|
4,013.30
-23.16%
|
5,223.20
+26.84%
|
4,117.90
|
| Cash And Cash Equivalents |
|
3,368.00
+66.12%
|
2,027.40
-26.28%
|
2,750.10
+73.92%
|
1,581.20
|
| Cash Equivalents |
|
2,853.10
+84.31%
|
1,548.00
-30.39%
|
2,223.90
+105.16%
|
1,084.00
|
| Cash Financial |
|
514.90
+7.41%
|
479.40
-8.89%
|
526.20
+5.83%
|
497.20
|
| Other Short Term Investments |
|
2,566.90
+29.26%
|
1,985.90
-19.70%
|
2,473.10
-2.51%
|
2,536.70
|
| Receivables |
|
1,628.20
+20.00%
|
1,356.80
+7.05%
|
1,267.50
+18.09%
|
1,073.30
|
| Accounts Receivable |
|
1,527.30
+24.64%
|
1,225.40
+8.42%
|
1,130.20
+19.97%
|
942.10
|
| Gross Accounts Receivable |
|
1,557.20
+23.97%
|
1,256.10
+8.54%
|
1,157.30
+19.99%
|
964.50
|
| Allowance For Doubtful Accounts Receivable |
|
-29.90
+2.61%
|
-30.70
-13.28%
|
-27.10
-20.98%
|
-22.40
|
| Other Receivables |
|
100.90
-23.21%
|
131.40
-4.30%
|
137.30
+4.65%
|
131.20
|
| Inventory |
|
1,840.00
+23.72%
|
1,487.20
+21.84%
|
1,220.60
+36.65%
|
893.20
|
| Raw Materials |
|
561.10
-0.50%
|
563.90
+24.02%
|
454.70
+18.75%
|
382.90
|
| Work In Process |
|
287.90
+39.96%
|
205.70
+28.64%
|
159.90
+0.00%
|
159.90
|
| Finished Goods |
|
991.00
+38.10%
|
717.60
+18.42%
|
606.00
+72.95%
|
350.40
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
376.40
+48.36%
|
253.70
+43.58%
|
176.70
+4.80%
|
168.60
|
| Total Non Current Assets |
|
10,679.20
-8.19%
|
11,632.20
+54.00%
|
7,553.50
+12.39%
|
6,721.00
|
| Net PPE |
|
5,342.40
+14.97%
|
4,646.60
+31.35%
|
3,537.60
+49.00%
|
2,374.20
|
| Gross PPE |
|
7,618.90
+16.71%
|
6,527.90
+28.01%
|
5,099.60
+41.18%
|
3,612.10
|
| Accumulated Depreciation |
|
-2,276.50
-21.01%
|
-1,881.30
-20.44%
|
-1,562.00
-26.18%
|
-1,237.90
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
479.70
+0.69%
|
476.40
+4.18%
|
457.30
+17.68%
|
388.60
|
| Buildings And Improvements |
|
2,833.90
+90.67%
|
1,486.30
+48.32%
|
1,002.10
+15.65%
|
866.50
|
| Machinery Furniture Equipment |
|
1,570.60
+15.95%
|
1,354.50
+19.26%
|
1,135.80
+20.57%
|
942.00
|
| Construction In Progress |
|
638.10
-60.89%
|
1,631.60
+20.44%
|
1,354.70
+122.59%
|
608.60
|
| Other Properties |
|
2,096.60
+32.77%
|
1,579.10
+37.35%
|
1,149.70
+42.57%
|
806.40
|
| Goodwill And Other Intangible Assets |
|
381.40
+2.94%
|
370.50
-4.46%
|
387.80
-2.64%
|
398.30
|
| Goodwill |
|
370.30
+6.56%
|
347.50
-0.34%
|
348.70
+0.06%
|
348.50
|
| Other Intangible Assets |
|
11.10
-51.74%
|
23.00
-41.18%
|
39.10
-21.49%
|
49.80
|
| Investments And Advances |
|
3,099.20
-35.69%
|
4,819.10
+127.32%
|
2,120.00
-19.19%
|
2,623.60
|
| Non Current Deferred Assets |
|
1,018.60
-2.54%
|
1,045.10
+14.78%
|
910.50
+37.00%
|
664.60
|
| Non Current Deferred Taxes Assets |
|
1,018.60
-2.54%
|
1,045.10
+14.78%
|
910.50
+37.00%
|
664.60
|
| Other Non Current Assets |
|
837.60
+11.55%
|
750.90
+25.65%
|
597.60
-9.50%
|
660.30
|
| Total Liabilities Net Minority Interest |
|
2,517.00
+13.71%
|
2,213.60
+8.29%
|
2,044.20
+9.82%
|
1,861.40
|
| Current Liabilities |
|
2,006.20
+14.95%
|
1,745.30
+5.22%
|
1,658.70
+16.64%
|
1,422.10
|
| Payables And Accrued Expenses |
|
851.10
+14.87%
|
740.90
-4.55%
|
776.20
+24.55%
|
623.20
|
| Payables |
|
380.50
+9.40%
|
347.80
+15.89%
|
300.10
+23.45%
|
243.10
|
| Accounts Payable |
|
255.10
+31.90%
|
193.40
+2.49%
|
188.70
+28.37%
|
147.00
|
| Current Accrued Expenses |
|
470.60
+19.72%
|
393.10
-17.43%
|
476.10
+25.26%
|
380.10
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
648.40
+21.06%
|
535.60
+22.73%
|
436.40
+8.67%
|
401.60
|
| Total Tax Payable |
|
125.40
-18.78%
|
154.40
+38.60%
|
111.40
+15.92%
|
96.10
|
| Current Deferred Liabilities |
|
506.70
+8.08%
|
468.80
+5.09%
|
446.10
+12.28%
|
397.30
|
| Current Deferred Revenue |
|
506.70
+8.08%
|
468.80
+5.09%
|
446.10
+12.28%
|
397.30
|
| Total Non Current Liabilities Net Minority Interest |
|
510.80
+9.08%
|
468.30
+21.48%
|
385.50
-12.25%
|
439.30
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
—
|
—
|
—
|
—
|
| Tradeand Other Payables Non Current |
|
193.60
-19.00%
|
239.00
+2.22%
|
233.80
-18.82%
|
288.00
|
| Non Current Deferred Liabilities |
|
91.40
+68.95%
|
54.10
+18.64%
|
45.60
+11.22%
|
41.00
|
| Non Current Deferred Revenue |
|
91.40
+68.95%
|
54.10
+18.64%
|
45.60
+11.22%
|
41.00
|
| Other Non Current Liabilities |
|
225.80
+28.88%
|
175.20
+65.13%
|
106.10
-3.81%
|
110.30
|
| Stockholders Equity |
|
17,824.00
+8.46%
|
16,433.70
+23.49%
|
13,307.60
+20.52%
|
11,041.90
|
| Common Stock Equity |
|
17,824.00
+8.46%
|
16,433.70
+23.49%
|
13,307.60
+20.52%
|
11,041.90
|
| Capital Stock |
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
|
| Common Stock |
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
+0.00%
|
0.40
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
355.10
-0.42%
|
356.60
+1.22%
|
352.30
+0.66%
|
350.00
|
| Ordinary Shares Number |
|
355.10
-0.42%
|
356.60
+1.22%
|
352.30
+0.66%
|
350.00
|
| Additional Paid In Capital |
|
10,768.50
+11.23%
|
9,681.30
+12.88%
|
8,576.40
+11.33%
|
7,703.90
|
| Retained Earnings |
|
7,011.80
+3.06%
|
6,803.30
+43.44%
|
4,743.00
+35.51%
|
3,500.10
|
| Gains Losses Not Affecting Retained Earnings |
|
43.30
+184.41%
|
-51.30
-320.49%
|
-12.20
+92.49%
|
-162.50
|
| Minority Interest |
|
117.70
+22.73%
|
95.90
+6.91%
|
89.70
+26.87%
|
70.70
|
| Other Equity Adjustments |
|
43.30
+184.41%
|
-51.30
-320.49%
|
-12.20
+92.49%
|
-162.50
|
| Total Equity Gross Minority Interest |
|
17,941.70
+8.54%
|
16,529.60
+23.38%
|
13,397.30
+20.56%
|
11,112.60
|
| Total Capitalization |
|
17,824.00
+8.46%
|
16,433.70
+23.49%
|
13,307.60
+20.52%
|
11,041.90
|
| Working Capital |
|
7,773.30
+44.87%
|
5,365.70
-13.86%
|
6,229.30
+28.95%
|
4,830.90
|
| Invested Capital |
|
17,824.00
+8.46%
|
16,433.70
+23.49%
|
13,307.60
+20.52%
|
11,041.90
|
| Total Debt |
|
—
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
—
|
—
|
—
|
—
|
| Net Tangible Assets |
|
17,442.60
+8.59%
|
16,063.20
+24.33%
|
12,919.80
+21.39%
|
10,643.60
|
| Tangible Book Value |
|
17,442.60
+8.59%
|
16,063.20
+24.33%
|
12,919.80
+21.39%
|
10,643.60
|
| Available For Sale Securities |
|
3,099.20
-35.69%
|
4,819.10
+127.32%
|
2,120.00
|
—
|
| Investmentin Financial Assets |
|
3,099.20
-35.69%
|
4,819.10
+127.32%
|
2,120.00
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
3,030.50
+25.49%
|
2,415.00
+33.15%
|
1,813.80
+21.67%
|
1,490.80
|
| Cash Flow From Continuing Operating Activities |
|
3,030.50
+25.49%
|
2,415.00
+33.15%
|
1,813.80
+21.67%
|
1,490.80
|
| Net Income From Continuing Operations |
|
2,876.60
+23.06%
|
2,337.50
+28.62%
|
1,817.30
+35.18%
|
1,344.40
|
| Depreciation Amortization Depletion |
|
677.10
+35.50%
|
499.70
+9.87%
|
454.80
+24.33%
|
365.80
|
| Depreciation |
|
614.70
+38.04%
|
445.30
+10.88%
|
401.60
+18.82%
|
338.00
|
| Amortization Cash Flow |
|
62.40
+14.71%
|
54.40
+2.26%
|
53.20
+91.37%
|
27.80
|
| Depreciation And Amortization |
|
677.10
+35.50%
|
499.70
+9.87%
|
454.80
+24.33%
|
365.80
|
| Amortization Of Intangibles |
|
62.40
+14.71%
|
54.40
+2.26%
|
53.20
+91.37%
|
27.80
|
| Other Non Cash Items |
|
—
|
37.70
+14.24%
|
33.00
+24.06%
|
26.60
|
| Stock Based Compensation |
|
788.20
+16.46%
|
676.80
+14.17%
|
592.80
+15.51%
|
513.20
|
| Deferred Tax |
|
19.10
+114.12%
|
-135.30
+51.82%
|
-280.80
-51.54%
|
-185.30
|
| Deferred Income Tax |
|
19.10
+114.12%
|
-135.30
+51.82%
|
-280.80
-51.54%
|
-185.30
|
| Operating Gains Losses |
|
-58.20
-31.08%
|
-44.40
-708.22%
|
7.30
-83.85%
|
45.20
|
| Gain Loss On Investment Securities |
|
-57.20
-32.10%
|
-43.30
-693.15%
|
7.30
-85.10%
|
49.00
|
| Change In Working Capital |
|
-1,272.30
-38.40%
|
-919.30
-18.22%
|
-777.60
-25.60%
|
-619.10
|
| Change In Receivables |
|
-301.70
-214.60%
|
-95.90
+48.52%
|
-186.30
-16.95%
|
-159.30
|
| Changes In Account Receivables |
|
-301.70
-214.60%
|
-95.90
+48.52%
|
-186.30
-16.95%
|
-159.30
|
| Change In Inventory |
|
-1,063.40
-28.12%
|
-830.00
-16.49%
|
-712.50
-30.35%
|
-546.60
|
| Change In Prepaid Assets |
|
-187.10
+19.28%
|
-231.80
-1057.85%
|
24.20
+118.73%
|
-129.20
|
| Change In Payables And Accrued Expense |
|
57.90
+14575.00%
|
-0.40
-100.96%
|
41.70
+95.77%
|
21.30
|
| Change In Payable |
|
57.90
+14575.00%
|
-0.40
-100.96%
|
41.70
+95.77%
|
21.30
|
| Change In Account Payable |
|
57.90
+14575.00%
|
-0.40
-100.96%
|
41.70
+95.77%
|
21.30
|
| Change In Other Working Capital |
|
187.90
+43.98%
|
130.50
+47.96%
|
88.20
+20.82%
|
73.00
|
| Change In Other Current Liabilities |
|
34.10
-68.51%
|
108.30
+429.18%
|
-32.90
-127.03%
|
121.70
|
| Investing Cash Flow |
|
665.80
+120.34%
|
-3,272.80
-808.86%
|
-360.10
-126.27%
|
1,370.80
|
| Cash Flow From Continuing Investing Activities |
|
665.80
+120.34%
|
-3,272.80
-808.86%
|
-360.10
-126.27%
|
1,370.80
|
| Net PPE Purchase And Sale |
|
-539.80
+51.42%
|
-1,111.20
-4.42%
|
-1,064.20
-99.89%
|
-532.40
|
| Purchase Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-539.80
+51.42%
|
-1,111.20
-4.42%
|
-1,064.20
-99.89%
|
-532.40
|
| Net Investment Purchase And Sale |
|
1,219.50
+156.44%
|
-2,160.60
-403.03%
|
713.00
-62.79%
|
1,916.00
|
| Purchase Of Investment |
|
-1,215.90
+76.34%
|
-5,139.60
-132.84%
|
-2,207.40
-57.73%
|
-1,399.50
|
| Sale Of Investment |
|
2,435.40
-18.25%
|
2,979.00
+2.01%
|
2,920.40
-11.92%
|
3,315.50
|
| Net Business Purchase And Sale |
|
-13.90
-1290.00%
|
-1.00
+88.76%
|
-8.90
+30.47%
|
-12.80
|
| Purchase Of Business |
|
-13.90
-1290.00%
|
-1.00
+88.76%
|
-8.90
+30.47%
|
-12.80
|
| Gain Loss On Sale Of Business |
|
-1.00
+9.09%
|
-1.10
|
0.00
+100.00%
|
-3.80
|
| Financing Cash Flow |
|
-2,364.10
-1666.67%
|
150.90
+152.47%
|
-287.60
+88.82%
|
-2,572.30
|
| Cash Flow From Continuing Financing Activities |
|
-2,364.10
-1666.67%
|
150.90
+152.47%
|
-287.60
+88.82%
|
-2,572.30
|
| Net Common Stock Issuance |
|
-2,295.30
|
0.00
+100.00%
|
-416.30
+84.03%
|
-2,607.40
|
| Common Stock Payments |
|
-2,295.30
|
0.00
+100.00%
|
-416.30
+84.03%
|
-2,607.40
|
| Repurchase Of Capital Stock |
|
-2,295.30
|
0.00
+100.00%
|
-416.30
+84.03%
|
-2,607.40
|
| Proceeds From Stock Option Exercised |
|
350.30
-18.42%
|
429.40
+44.92%
|
296.30
+26.73%
|
233.80
|
| Net Other Financing Charges |
|
-419.10
-50.48%
|
-278.50
-66.17%
|
-167.60
+15.65%
|
-198.70
|
| Changes In Cash |
|
1,332.20
+288.46%
|
-706.90
-160.62%
|
1,166.10
+303.08%
|
289.30
|
| Effect Of Exchange Rate Changes |
|
12.80
+1700.00%
|
-0.80
-124.24%
|
3.30
-38.89%
|
5.40
|
| Beginning Cash Position |
|
2,062.40
-25.55%
|
2,770.10
+73.06%
|
1,600.70
+22.57%
|
1,306.00
|
| End Cash Position |
|
3,407.40
+65.22%
|
2,062.40
-25.55%
|
2,770.10
+73.06%
|
1,600.70
|
| Free Cash Flow |
|
2,490.70
+91.03%
|
1,303.80
+73.93%
|
749.60
-21.79%
|
958.40
|
| Income Tax Paid Supplemental Data |
|
537.90
+15.31%
|
466.50
+4.18%
|
447.80
+0.81%
|
444.20
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-04-22 View
- 8-K2026-04-21 View
- 42026-03-11 View
- 42026-03-10 View
- 42026-03-05 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 8-K2026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|